Cargando…
Open Access Target Validation Is a More Efficient Way to Accelerate Drug Discovery
There is a scarcity of novel treatments to address many unmet medical needs. Industry and academia are finally coming to terms with the fact that the prevalent models and incentives for innovation in early stage drug discovery are failing to promote progress quickly enough. Here we will examine how...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456377/ https://www.ncbi.nlm.nih.gov/pubmed/26042736 http://dx.doi.org/10.1371/journal.pbio.1002164 |